238 related articles for article (PubMed ID: 16338237)
1. Synthesis and antitumor activity of simplified ecteinascidin-saframycin analogs.
Liu ZZ; Wang Y; Tang YF; Chen SZ; Chen XG; Li HY
Bioorg Med Chem Lett; 2006 Mar; 16(5):1282-5. PubMed ID: 16338237
[TBL] [Abstract][Full Text] [Related]
2. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
4. Chemistry of ecteinascidins. Part 3: preparation of 2'-N-acyl derivatives of ecteinascidin 770 and evaluation of cytotoxicity.
Saktrakulkla P; Toriumi S; Tsujimoto M; Patarapanich C; Suwanborirux K; Saito N
Bioorg Med Chem; 2011 Aug; 19(15):4421-36. PubMed ID: 21752654
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship study of potent cytotoxic analogues of the marine alkaloid Lamellarin D.
Pla D; Marchal A; Olsen CA; Francesch A; Cuevas C; Albericio F; Alvarez M
J Med Chem; 2006 Jun; 49(11):3257-68. PubMed ID: 16722644
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity of 3-aryl acrylic amide derivatives of the simplified saframycin-ecteinascidin skeleton prepared from L-dopa.
Guo J; Dong W; Liu W; Yan Z; Wang N; Liu Z
Eur J Med Chem; 2013 Apr; 62():670-6. PubMed ID: 23434640
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antitumor properties of novel saframycin analogs in vitro and in vivo.
Spencer JR; Sendzik M; Oeh J; Sabbatini P; Dalrymple SA; Magill C; Kim HM; Zhang P; Squires N; Moss KG; Sukbuntherng J; Graupe D; Eksterowicz J; Young PR; Myers AG; Green MJ
Bioorg Med Chem Lett; 2006 Sep; 16(18):4884-8. PubMed ID: 16870445
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicities and structure-activity relationships of natural and unnatural lamellarins toward cancer cell lines.
Chittchang M; Batsomboon P; Ruchirawat S; Ploypradith P
ChemMedChem; 2009 Mar; 4(3):457-65. PubMed ID: 19152364
[TBL] [Abstract][Full Text] [Related]
9. Lamellarin D bioconjugates I: Synthesis and cellular internalization of PEG-derivatives.
Pla D; Francesch A; Calvo P; Cuevas C; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1100-11. PubMed ID: 19472995
[TBL] [Abstract][Full Text] [Related]
10. Chemistry of ecteinascidins. Part 4: preparation of 2'-N-acyl ecteinascidin 770 derivatives with improved cytotoxicity profiles.
Tsujimoto M; Lowtangkitcharoen W; Mori N; Pangkruang W; Putongking P; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2013; 61(10):1052-64. PubMed ID: 24088697
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and cytotoxicity of novel hexacyclic saframycin-ecteinascidin analogs.
Lu X; Pan X; Guan B; Liu Z
Org Biomol Chem; 2020 Jan; 18(2):237-249. PubMed ID: 31782476
[TBL] [Abstract][Full Text] [Related]
12. Lamellarin D bioconjugates II: Synthesis and cellular internalization of dendrimer and nuclear location signal derivatives.
Pla D; Martí M; Farrera-Sinfreu J; Pulido D; Francesch A; Calvo P; Cuevas C; Royo M; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1112-21. PubMed ID: 19472996
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D.
Zheng L; Gao T; Ge Z; Ma Z; Xu J; Ding W; Shen L
Eur J Med Chem; 2021 Mar; 214():113226. PubMed ID: 33582387
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Rhee HK; Lim SY; Jung MJ; Kwon Y; Kim MH; Choo HY
Bioorg Med Chem; 2009 Nov; 17(21):7537-41. PubMed ID: 19800803
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition.
Sakai K; Soshima T; Hirose Y; Ishibashi F; Hirao S
Bioorg Med Chem Lett; 2024 May; 104():129710. PubMed ID: 38518997
[TBL] [Abstract][Full Text] [Related]
16. Chemistry of ecteinascidins. Part 2. Preparation of 6'-O-acyl derivatives of stable ecteinascidin and evaluation of cytotoxicity.
Puthongking P; Patarapanich C; Amnuoypol S; Suwanborirux K; Kubo A; Saito N
Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):1010-6. PubMed ID: 16819221
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno[2,1-b]phenanthrene analogue of Lamellarin D.
Cananzi S; Merlini L; Artali R; Beretta GL; Zaffaroni N; Dallavalle S
Bioorg Med Chem; 2011 Aug; 19(16):4971-84. PubMed ID: 21783369
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric synthesis and cytotoxicity of (-)-saframycin A analogues.
Dong W; Liu W; Yan Z; Liao X; Guan B; Wang N; Liu Z
Eur J Med Chem; 2012 Mar; 49():239-44. PubMed ID: 22284268
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxicity of a novel series of saframycin-ecteinascidin analogs containing tetrahydro-β-carboline moieties.
Lu X; Pan X; Yang Y; Ji M; Chen X; Xiao Z; Liu Z
Eur J Med Chem; 2017 Jul; 135():260-269. PubMed ID: 28456034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]